Revolution Medicines’ pancreatic cancer drug nears European approval
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
European regulators have recommended approval of Revolution Medicines’ Rasonque for pancreatic cancer, bringing the drug closer to the European market after it received clearance from the US Food and Drug Administration.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu